In this regard, TCDD-induced EGFR expression changes in breast cancer cells were associated with downstream signaling activation and apoptosis inhibition, whereas this effect was reversed by an AhR antagonist, indicating a tumor-promoting effect of EGFR-mediated AhR signaling (97). The gene discussed is AHR; the disease is breast carcinoma.